Liver Cancer

Protocols
11 protocols meet the specified criteria
Disease Site: Liver
Protocol No. Title
OCR13631 Molecular Analysis for Therapy Choice (MATCH)
OCR14527 A Phase 3 Randomized, Open-Label Study Comparing Pexa-Vec (Vaccinia GM-CSF/Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy
OCR15092 An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors
OCR15212 Assessing the Benefits of PhotoVoice in Pancreatic Cancer and Other Advanced Cancers
OCR15562 A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma
OCR15873 A Phase 1/2 study exploring the safety, tolerability, and efficacy of INCAGN01876 in combination with immune therapies in subjects with advanced or metastatic malignancies
OCR16016 DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
OCR16937 A Phase 1 Study of NLG802 for Adult Patients with Recurrent Advanced Solid Tumors
OCR17279 Phase I Clinical Trial of VX-970 in Combination with the Topoisomerase I Inhibitor Irinotecan in Patients with Advanced Solid Tumors
OCR17388 A Phase 1 Study of Pembrolizumab (MK-3475) in Combination with Recombinant Interleukin-12 in Patients with Solid Tumors
OCR17893 Palliative Care for Elderly Outpatients